Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19

There is scarce data on the impact of the presence of mediastinal lymphadenopathy on the prognosis of coronavirus-disease 2019 (COVID-19). We aimed to investigate whether its presence is associated with increased risk for 30-day mortality in a large group of patients with COVID-19.

Source: Clinical Imaging - February 1, 2021 Category: Radiology Authors: Celal Satici, Ferhat Cengel, Okan Gurkan, Mustafa Asim Demirkol, Elif Sargin Altunok, Sinem Nihal Esatoglu Tags: Cardiothoracic Imaging Source Type: research